PET staging improves survival of patients with lung cancer

06/27/2013 | AuntMinnie.com (free registration)

Pretreatment PET staging of limited-stage small-cell lung cancer can improve patient survival, according to a study published in the Journal of Thoracic Oncology. PET-staged patients demonstrated three-year overall survival of 47%, while those who were not staged with PET had 19% survival, the study said. Median survival after diagnosis among PET-staged patients was 32 months, while it was 17 months for patients not staged with PET.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ